Sort
39,280 grants matching “leukemia”
Mechanism of non-oncogene addiction
$363,713Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · CA
The role of glutaminolysis as a therapeutic target in T-ALL
$363,713Daniel Herranz · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
$363,713Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2025 · CA
Project 4: Novel epigenetic treatment of IDH mutant gliomas
$363,680Harley I Kornblum · University Of California Los Angeles · P50 · FY2017 · CA
Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug
$363,671Weidong Wang · National Institute On Aging · ZIA · FY2025 · AG
Regulation of transcription and tumor suppression by MTG family members
$363,613Scott Hiebert · Vanderbilt University · R01 · FY2014 · CA
Discovery of clinically distinct CLL subgroups by integrative mapping of large-scale CLL genetic, expression and clinical data
$363,573Gad A Getz · Dana-Farber Cancer Inst · P01 · FY2016 · CA
Project 1: Decoding, Modeling and Targeting Oncohistones and an Oncohistone-like Protein
$363,562Nada Jabado · Rockefeller University · P01 · FY2021 · CA
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment
$363,465Steven David Mittelman · University Of California Los Angeles · R01 · FY2018 · CA
Novel statistical tools for cell line specific epigenetic analysis
$363,452Wenxuan Zhong · University Of Georgia · R01 · FY2016 · GM
Novel statistical tools for cell line specific epigenetic analysis
$363,452Wenxuan Zhong · University Of Georgia · R01 · FY2017 · GM
Novel statistical tools for cell line specific epigenetic analysis
$363,452Wenxuan Zhong · University Of Georgia · R01 · FY2015 · GM
Genetic and Epigenetic Regulation of Hematopoiesis.
$363,400Shireen Saleque · City College Of New York · SC1 · FY2010 · HL
Multi-Scale Cancer Modeling: From Cell Phenotypes to Cancer Spread and Response
$363,394Vittorio Cristini · University Of Southern California · U54 · FY2011 · CA
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
$363,375Carlo M Croce · Ohio State University · R01 · FY2014 · CA
Glucocorticoids in Lymphoblastic Leukemia
$363,320Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2013 · CA
Pediatric Oncology Clinical Research Training Program
$363,293Baylor College Of Medicine · K12 · FY2002 · CA
Structure/function studies of CTLD NK immunoreceptors
$363,281Roland K Strong · Fred Hutchinson Cancer Research Center · R01 · FY2007 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP
$363,280Tufts Medical Center · U10 · FY2001 · CA
Signaling Pathways in MDS
$363,278Kathleen Miho Sakamoto · Stanford University · R01 · FY2016 · DK
A mouse model for human gastrointestinal stromal tumor
$363,278Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Ah Receptor Dysregulation Alters Hematopoietic Stem Cells
$363,273Thomas A Gasiewicz · University Of Rochester · R01 · FY2013 · ES
Transcriptional regulation of TAL1/SCL in normal and malignant hematopoiesis
$363,269Suming Huang · University Of Florida · R01 · FY2008 · HL
Identifying the pathways that drive progression of the MPNs to AML
$363,268John D Crispino · Northwestern University At Chicago · R01 · FY2020 · CA
The roles of lipid metabolism in the maintenance of hematopoietic stem cells
$363,225Keisuke Ito · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DK